Bioventus enters $400M credit facility to refinance existing debt

Bioventus Inc.

$100M revolving credit facility and $300M term loan A facility, maturing July 31, 2030.
Initial interest rate: Term SOFR + 2.50% margin, subject to performance grid (1.75%-2.75%).
$30M drawn on revolver at closing; proceeds used to refinance existing 2019 credit facilities.
Financial covenants: max total net leverage ratio 4.00x (step down to 3.50x), min interest coverage 2.50x.
Facility secured by substantially all assets; includes $7.5M L/C and $7.5M swingline subfacilities.

item 1.01item 2.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.